- Home
- MRM
as 11-14-2024 11:35am EST
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
| Founded: | 2000 | Country: | Japan |
| Employees: | N/A | City: | N/A |
| Market Cap: | 12.2M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 11.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.16 | EPS Growth: | -17.96 |
| 52 Week Low/High: | $2.27 - $8.39 | Next Earning Date: | 12-30-2022 |
| Revenue: | $48,438,179 | Revenue Growth: | -1.81% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest MEDIROM Healthcare Technologies Inc. News
MRM Breaking Stock News: Dive into MRM Ticker-Specific Updates for Smart Investing
TipRanks
6 days ago
MEDIROM Reports Revenue Growth Despite Asset Decline
GlobeNewswire
8 days ago
Healthy and Beauty Synergies: MEDIROM Healthcare Technologies and SBC Medical Group Holdings Announce Business Alliance
GlobeNewswire
23 days ago
Lead Real Estate Co., LTD Introduces Fitness Tracker “MOTHER Bracelet®︎” to ENT TERRACE and Invites Activities that Lead to Social Support
TipRanks
a month ago
MEDIROM Partners with Elematec to Boost Health Tech
MT Newswires
a month ago
Sector Update: Health Care Stocks Slide Late Afternoon
MT Newswires
a month ago
Sector Update: Health Care
MT Newswires
a month ago
Top Midday Gainers
MT Newswires
a month ago
Medirom Healthcare Shares Rise After Investment, Partnership With Elematec
Compare MRM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRM MEDIROM Healthcare Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.